September 14, 2017
Targovax Receives 2017 Nordic Stars Award
Media
September 13, 2017
Onxeo Grants Exclusive Worldwide License of Validive® developed for the treatment of oral severe mucositis to Monopar Therapeutics
September 12, 2017
2017 Half-Year Results
September 11, 2017
Targovax ASA: Three posters presented at ESMO conference
September 11, 2017
Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma
September 08, 2017
EBV treatment may be alternative to lung volume reduction surgery for patients with severe emphysema
September 05, 2017
Strongbridge Biopharma plc to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 04, 2017
Nordic Nanovector to Present at Pareto Securities’ 8th Annual HealthCare Conference
August 25, 2017
Oncopeptides AB Interim Report April – June 2017
August 24, 2017
Targovax ASA: Second quarter and first half 2017 results
